Haemonetics (HAE) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $1.34.
- Haemonetics' Debt to Equity fell 51.22% to $1.34 in Q4 2025 from the same period last year, while for Dec 2025 it was $1.34, marking a year-over-year decrease of 51.22%. This contributed to the annual value of $1.49 for FY2025, which is 7731.98% up from last year.
- Latest data reveals that Haemonetics reported Debt to Equity of $1.34 as of Q4 2025, which was down 51.22% from $1.44 recorded in Q3 2025.
- Over the past 5 years, Haemonetics' Debt to Equity peaked at $1.49 during Q1 2025, and registered a low of $0.84 during Q1 2024.
- Over the past 5 years, Haemonetics' median Debt to Equity value was $1.09 (recorded in 2021), while the average stood at $1.13.
- Per our database at Business Quant, Haemonetics' Debt to Equity skyrocketed by 14689.48% in 2022 and then tumbled by 2396.26% in 2023.
- Over the past 5 years, Haemonetics' Debt to Equity (Quarter) stood at $1.12 in 2021, then fell by 11.59% to $0.99 in 2022, then decreased by 6.6% to $0.92 in 2023, then skyrocketed by 46.35% to $1.35 in 2024, then decreased by 0.51% to $1.34 in 2025.
- Its Debt to Equity was $1.34 in Q4 2025, compared to $1.44 in Q3 2025 and $1.39 in Q2 2025.